Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- CND Life Sciences
- Study ID
- NCT07428447
- Status
- Recruiting
Conditions
- Essential Tremor
- Essential Tremor, Movement Disorders
- Essential Tremor-plus
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 85 Years
- Healthy Volunteers
- Not accepted
Study Details
Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting to PD annually. Post-mortem studies reveal Lewy body pathology in some ET patients, suggesting a subset may have prodromal PD. Current diagnostic tools (DaTscan, SYNTap) are either insufficiently sensitive for early disease, too expensive, or too invasive for routine screening. The Syn-One Test offers a minimally invasive approach to detect phosphorylated α-synuclein (P-SYN) pathology in skin biopsies. Primary Objectives 1. Identify which ET patients have P-SYN pathology indicative of prodromal PD 2. Predict which patients are most likely to phenoconvert to PD
Key Dates
- Start date
- Feb 18, 2026
- Status verified
- Feb 2026
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Essential TremorThose diagnosed with Essential Tremor
- Arm: Essential Tremor PlusThose diagnosed with Essential Tremor Plus
Primary Outcome Measure
Quantity of P-SYN in skin [ Time Frame: From enrollment to completion of study participation from Baseline to Month 12 and then to Month 24 ]
Central Contacts
- Jeannie Director of Clinical Research480-434-6446
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CND Clinical Research Center | Scottsdale | Arizona | 85258 |
Find similar trials in Scottsdale, AZ
Related Studies
- Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting · Boston Scientific Corporation · Phoenix, Arizona
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Physiological Brain Atlas DevelopmentRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Deep Brain Stimulation Surgery for Movement DisordersRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland